
A step towards developing treatment for the newly emerging and often fatal disease have been identified in terms of natural human antibodies against the virus that causes MERS. Currently there is no vaccine or antiviral treatment for MERS, a severe respiratory disease with a mortality rate of more than 40 percent that was first reported in Saudi Arabia in 2012. In laboratory studies reported in the "Proceedings of the National Academy of Sciences" (PNAS), ...
Read More
No comments:
Post a Comment